Avondale Wealth Management Pfizer Inc Transaction History

Avondale Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $23,265 - $27,585	-500 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $40,522 - $45,701	-1,210 Reduced 70.76%	500 $18,000
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $33,068 - $42,049	988 Added 136.84%	1,710 $63,000
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $36,980 - $41,520	-1,000 Reduced 58.07%	722 $31,000
Q4 2017 Apr 27, 2018	BUY	$33.26 - $35.29 $57,273 - $60,769	1,722	1,722 $62,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Avondale Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Avondale Wealth Management with notifications on news.